By standardizing the workflow for patient assessment before implantation of a new transcatheter aortic valve (redo TAV), heart teams can better assess the feasibility of redo-TAV for any index TAV, as well as identify patients anatomically unsuitable or suboptimal for this procedure, a new review suggests.